Arovella Therapeutics (FRA:E4NA) EV-to-Revenue : 503.57 (As of Jun. 01, 2025)

Arovella Therapeutics EV-to-Revenue Chart

Arovella Therapeutics Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
EV-to-Revenue		Get a 7-Day Free Trial					8.21	80.82	32.02	91.92	7,903.76

Arovella Therapeutics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															-	91.92	-	7,903.76	-

Competitive Comparison of Arovella Therapeutics's EV-to-Revenue

For the Biotechnology subindustry, Arovella Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arovella Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arovella Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Arovella Therapeutics's EV-to-Revenue falls into.

Arovella Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Arovella Therapeutics's EV-to-Revenue for today is calculated as:

Arovella Therapeutics's current Enterprise Value is €44.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arovella Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arovella Therapeutics  (FRA:E4NA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Arovella Therapeutics's PS Ratiofor today is calculated as:

Arovella Therapeutics's share price for today is €0.0385.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arovella Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Arovella Therapeutics Business Description